CAD 0.03
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 662.27 Thousand CAD | -59.01% |
2022 | 1.61 Million CAD | -32.4% |
2021 | 2.38 Million CAD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 398.33 Thousand CAD | -27.63% |
2024 Q3 | 202.11 Thousand CAD | -49.26% |
2024 Q1 | 550.43 Thousand CAD | -16.89% |
2023 Q3 | 859.97 Thousand CAD | -11.72% |
2023 FY | 662.27 Thousand CAD | -59.01% |
2023 Q1 | 1.21 Million CAD | -24.71% |
2023 Q2 | 974.09 Thousand CAD | -19.92% |
2023 Q4 | 662.27 Thousand CAD | -22.99% |
2022 Q3 | 1.87 Million CAD | -6.74% |
2022 FY | 1.61 Million CAD | -32.4% |
2022 Q4 | 1.61 Million CAD | -13.87% |
2022 Q1 | - CAD | -100.0% |
2022 Q2 | 2.01 Million CAD | 0.0% |
2021 Q4 | 2.38 Million CAD | 0.0% |
2021 FY | 2.38 Million CAD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
AI/ML Innovations Inc. | 329.68 Thousand CAD | -100.878% |
Pangenomic Health Inc. | 71.47 Thousand CAD | -826.537% |
nDatalyze Corp. | 877.9 Thousand CAD | 24.563% |
Treatment.Com International Inc. | 739.3 Thousand CAD | 10.42% |
Unidoc Health Corp. | 517.08 Thousand CAD | -28.078% |